2011 annual financial data
Corcept Therapeutics 2011 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -32,332,000 USD and net income was -32,354,000 USD.
Operating cash flow was -27,400,000 USD.
Get free Corcept Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -32,332,000 USD
- Net income
- -32,354,000 USD
- Operating cash flow
- -27,400,000 USD